1,028
Views
12
CrossRef citations to date
0
Altmetric
Infectious Disease: Original article

A retrospective study to assess the epidemiological and economic burden of pneumococcal diseases in adults aged 50 years and older in Taiwan

, , , , &
Pages 312-319 | Accepted 21 Feb 2014, Published online: 13 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Terapong Tantawichien, Li Yang Hsu, Omer Zaidi, Mark Bernauer, Frieda Du, Eriko Yamada, Jin Oh Kim & Isaya Sukarom. (2022) Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas. Expert Review of Vaccines 21:2, pages 215-226.
Read now

Articles from other publishers (11)

Thundon Ngamprasertchai, Chayanis Kositamongkol, Saranath Lawpoolsri, Pinyo Rattanaumpawan, Viravarn Luvira, Piriyaporn Chongtrakool, Jaranit Kaewkungwal, Kulkanya Chokephaibulkit & Pochamana Phisalprapa. (2023) A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult. Frontiers in Public Health 11.
Crossref
Zhenfei Pi, Kiyoshi Aoyagi, Kazuhiko Arima, Xiaoliang Wu, Zhaojia Ye & Yawen Jiang. (2023) Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study. Vaccines 11:1, pages 161.
Crossref
Jia Guo, Haijun Zhang, Haonan Zhang, Xiaozhen Lai, Jiahao Wang, Huangyufei Feng & Hai Fang. (2023) Cost-effectiveness of pneumococcal vaccines among adults aged 65 years and older in China: A comparative study. Vaccine 41:3, pages 716-723.
Crossref
Shih-Tsung Huang, Yhu-Chering Huang, Edward Kuo, Ya-Min Yang & Fei-Yuan Hsiao. (2022) Impacts of Catch-Up Immunization program with the 13-Valent pneumococcal Conjugate vaccine in Taiwan: Focus on age-stratified differences and high-risk population (2001–2015). Vaccine 40:43, pages 6225-6234.
Crossref
Xiaodong Sun, Yuekun Tang, Xiaoying Ma, Xiang Guo, Zhuoying Huang, Jia Ren, Jing Qiu, Hongli Jiang & Yihan Lu. (2021) Cost-Effectiveness Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine Program for the Elderly Aged 60 Years or Older in Shanghai, China. Frontiers in Public Health 9.
Crossref
Daqin Chen, Zhaojia Ye, Zhenfei Pi, Satoshi Mizukami, Kiyoshi Aoyagi & Yawen Jiang. (2021) Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China. Vaccine 39:16, pages 2237-2245.
Crossref
Nianli Xing, Wing-yin Cheung, Minghuan Jiang & Joyce H.S. You. (2019) Standing orders program of pneumococcal vaccination for hospitalized elderly patients in Hong Kong: A cost-effectiveness analysis. American Journal of Infection Control.
Crossref
H. J. Heppner, A. Leischker, P. Wutzler & A. Kwetkat. (2017) Impfungen im höheren LebensalterVaccination in advanced age. Der Internist 59:2, pages 205-212.
Crossref
Daijun Zhao, Ruoyan Gai Tobe, Min Cui, Jinchun He & Bin Wu. (2016) Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China. Vaccine 34:50, pages 6158-6165.
Crossref
Soraya Azmi, Syed Mohamed Aljunid, Namaitijiang Maimaiti, Al-Abed Ali, Amrizal Muhammad Nur, Madeleine De Rosas-Valera, Joyce Encluna, Rosminah Mohamed, Bambang Wibowo, Kalsum Komaryani & Craig Roberts. (2016) Assessing the burden of pneumonia using administrative data from Malaysia, Indonesia, and the Philippines. International Journal of Infectious Diseases 49, pages 87-93.
Crossref
Joon Young Song & Hee Jin Cheong. (2014) Pneumococcal vaccine. Journal of the Korean Medical Association 57:9, pages 780.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.